|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/17 | (nenurodyta) |
| A61K 38/20 | (nenurodyta) | ||
| A61K 31/58 | (nenurodyta) | ||
| A61K 35/15 | (nenurodyta) | ||
| C12Q 1/68 | (nenurodyta) | ||
| C12N 15/113 | (nenurodyta) | ||
| C12N 15/115 | (nenurodyta) | ||
| A61K 39/00 | (nenurodyta) | ||
| C07K 16/28 | (nenurodyta) |
| (11) | Number of the document | 2421888 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10766694.3 |
| Date of filing the European patent application | 2010-04-06 | |
| (97) | Date of publication of the European application | 2012-02-29 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-21 |
| (46) | Date of publication of the claims translation | 2018-05-25 |
| (86) | Number | PCT/FI2010/050266 |
| Date | 2010-04-06 |
| (87) | Number | WO 2010/122217 |
| Date | 2010-10-28 |
| (30) | Number | Date | Country code |
| 20090161 | 2009-04-22 | FI |
| (72) |
JALKANEN, Sirpa, FI
SALMI, Marko, FI
JALKANEN, Markku, FI
|
| (73) |
Faron Pharmaceuticals OY,
Joukahaisenkatu 6, 20520 Turku,
FI
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Clever-1 receptorių antagonistai, skirti blokuoti imunitetą slopinančius 2 tipo makrofagus |
| CLEVER-1 Receptor Antagonists for blocking immune-inhibitory type 2 macrophages. |
| Payment date | Validity (years) | Amount | |
| 2026-03-18 | 17 | 347.00 EUR |
| 2027-04-06 |